How would you approach a premenopausal woman with HR+, HER2- metastatic breast and a PIK3CA mutation?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Baptist Health South Florida
Answered on
Ovarian ablation of some sort + AI + CDK 4/6 inhibitor. At relapse, consider fulvestrant + alpelisib.
Join for free or sign in to see the full answer